QualityStocks

[QualityStocks]

QualityStocksNewsBreaks – Pressure BioSciences Inc.’s (PBIO) New HUB880 Explorer Enables Researchers to Reach Higher Pressure Levels

Pressure BioSciences (OTCQB: PBIO) recently unveiled the HUB880 Explorer, a high-pressure based system that will empower public health, microbiology, food science, agriculture and other research scientists to study the manner in which pressure can kill food pathogens. A recent article discussing the company reads, “Through the use of the new HUB880 Explorer, researchers will become capable of reaching higher pressure levels and working with larger sample sizes. This way, the manner in which pathogens contribute to spoilage and safety hazards will be studied more thoroughly. Because of this enhancement, the HUB880 Explorer could potentially lead to higher revenue levels in the foreseeable future, Dr. Lawrence noted. … Pressure BioSciences President and CEO Richard T. Schumacher said that the company is concentrating its efforts in two fields – pressure-based research instruments for use in scientific research settings and the Ultra Shear Technology, which is a scalable food processing method. The aim of UST is to address the limitations of using standard high-pressure processing and other food processing technologies in the quest to develop a scalable, enabling food processing method that can result in safer, great tasting, longer shelf-life, clean label (no chemical additives) food.”

To view the full article, visit http://ibn.fm/R4e9d

About Pressure BioSciences Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). PBIO’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) the use of its recently acquired PreEMT technology from BaroFold, Inc. to allow entry into the biologics contract research services sector, and (2) the use of its recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com